IP Library › Granted Patent US 7,910,547
Granted Patent B2
US 7,910,547 · App. 10/583,879 · Granted Mar 22, 2011

Tissue regeneration method

Assignee: Augustinus Bader
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,547
App. No.
10/583,879
Granted
Mar 22, 2011
Kind
B2
Abstract

The invention relates to the use of haematopoietic growth factors, in particular erythropoietin (EPO) and thrombopoietin (TPO), or derivatives, analogues or parts thereof, for promoting structural tissue regeneration.

Claims (3)

1. A method for healing of dermal wounds in an individual, the method comprising mechanically debriding the wound bed, and then introducing EPO into the blood coagulum by topical administration.

2. The method according to claim 1 , characterized in that the EPO has additional glycosylation sites compared with native EPO.

3. The method according to claim 1 , characterized in that the EPO is conjugated with polyethylene glycol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2009
From: BIONETHOS HOLDING GMBH
To: BADER, AUGUSTINUS
Reel/Frame 022274/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2006
From: BADER, AUGUSTINUS
To: BIONETHOS HOLDING GMBH
Reel/Frame 018377/0016 →
Priority Claims (2)
DE 103 61 813 · Dec 30, 2003 · national
EP 03029961 · Dec 30, 2003 · regional
Continuity (1)
Related Publication 20080031850A1 · Feb 7, 2008